Developing innovative strategies of tumor ‑infiltrating lymphocyte therapy for tumor treatment

Oncol Rep. 2024 Jun;51(6):85. doi: 10.3892/or.2024.8744. Epub 2024 Apr 26.ABSTRACTCancer is the main cause of global mortality, and thus far, effective therapeutic strategies for cancer treatment are in high demand. Adoptive transfer of tumor‑infiltrating lymphocytes (TILs) represents a promising avenue in immunotherapy for the management of malignancies. The clinical safety and efficacy of TIL‑based therapy have been established through numerous rigorous clinical trials. However, the efficacy of TIL infusion in inducing an anti‑tumor response is limited to a subset of clinical patients with cancer. Therefore, there is an urgent need to develop innovative strategies aimed at enhancing the effectiveness of TIL‑based therapy. In the present review, the developmental history of TIL‑based therapy was systematically summarized and analyzed, while also presenting a unique perspective on enhancing the multi‑dimensional anti‑tumor capabilities of TILs. The insight and conclusions presented in this review may contribute to improving the efficacy of TIL‑based therapy and expediting its development.PMID:38666543 | DOI:10.3892/or.2024.8744
Source: Oncology Reports - Category: Cancer & Oncology Authors: Source Type: research